Quantcast

Latest Glibenclamide Stories

2014-03-06 23:28:29

Diabetic Patients Can Obtain Discounts of 10%-75% on Lantus and Metformin San Antonio, TX (PRWEB) March 06, 2014 As of 2013, diabetes affected nearly 26 million people—more than 8% of the U.S. population. This number includes those diagnosed with "pre-diabetes" as well as those who manage their condition with diet and exercise, oral medication, or by injecting insulin. Diabetes is a serious condition, and improper management can lead to blindness, limb atrophy and...

2013-12-05 23:48:03

No data on patients with metformin intolerance or contraindication The drug saxagliptin (trade name: Onglyza) has been approved also as monotherapy in Germany since July 2013 for certain adults with type 2 diabetes mellitus. It is an option when drug treatment is needed, but the drug metformin is not tolerated or cannot be used. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency...

2013-06-06 11:37:43

Manufacturer's dossier did not contain suitable data for any therapeutic indication Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy. No such...

2013-04-29 16:01:28

Drug manufacturer did not submit suitable data in its dossier The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this fixed combination product offers an added...

2012-06-25 21:12:15

Compared to another popular drug, three widely used diabetes medications are associated with a greater risk of death, a large new analysis finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston. The drugs, glipizide, glyburide, and glimepiride, are known as sulfonylureas, which help decrease blood-sugar levels among type 2 diabetes patients by stimulating the pancreas to produce insulin. In the past, these medications were considered...

2012-01-06 14:45:41

Drug manufacturer deviates from appropriate comparator therapy specified by the G-BA Linagliptin (trade name: Trajenta®) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise. It is an option for patients who do not tolerate or should not take the usual treatment with the drug metformin. Moreover, linagliptin can be added if...

2011-04-07 13:54:16

New research suggests that several commonly prescribed drugs for type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin. Insulin secretagogues (ISs), such as glimepiride, glibenclamide (known as glyburide in the USA and Canada), gliclazide and tolbutamide, have been used to treat type 2 diabetes since the 1950-1970s, Nevertheless, the long-term risk associated with these drugs has...

2010-11-01 11:18:00

SAN BERNARDINO, Calif., Nov. 1, 2010 /PRNewswire/ -- According to the American Diabetes Association, total costs of diagnosed diabetes in the United States in 2007 were estimated at $174 billion. Millions of Americans have been diagnosed with type II diabetes and many more are unaware that they are at risk or in fact living with the disease. Individuals with type II diabetes use pills to manage their diabetes and these medications can be costly. Beginning in November, National Diabetes...

2009-06-04 07:31:00

LONDON, June 4 /PRNewswire/ -- The latest issue of the online journal Diabetic Hypoglycemia (http://www.hypodiab.com) features an authoritative review on sulfonylureas by Professor Ian Campbell, a leading expert in oral hypoglycemia therapy. Professor Campbell's review focuses on sulfonylurea-induced hypoglycemia (SIH), which is a well-recognized side-effect of this class of therapy for type 2 diabetes. In the review he discusses the incidence of SIH, with particular reference to the...

2008-08-26 15:01:06

According to news.gov.hk: The Department of Health urges people not to buy or use a red and yellow capsule labelled "Lu Quan" which is found to contain an undeclared drug that may cause serious side effects. A 73-year-old man - who had bought the product in Shenzhen and taken it - was admitted to Kwong Wah Hospital on August 13 after being found unconscious. His blood glucose level was very low on admission. Glibenclamide and sildenafil, which are used to treat diabetics and male sexual...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related